RTTNews | Aug 24, 2020 08:12AM EDT

08:11 Monday, August 24, 2020 (RTTNews.com) - Beckman Coulter announced the launch of its Access SARS-CoV-2 Immunoglobulin M assay, new antibody test. The company said the test showed 99.9% specificity against 1,400 negative samples and 98.3% sensitivity at 15-30 days post-symptom onset.

"Our new SARS-CoV-2 IgM assay provides information about an individual's immune status with a positive predicative value of 95.5% in a population with disease incidence as low as 3%," said Julie Sawyer Montgomery, president of Beckman Coulter.

Beckman Coulter is an operating company of Danaher Corp. (DHR), and is headquartered in Brea, Calif.

Read the original article on RTTNews ( https://www.rttnews.com/3123392/beckman-coulter-launches-sars-cov-2-igm-antibody-test.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved